Bad science Medicine Pseudoscience Quackery

The astroturf effort promoting hydroxychloroquine as a treatment for COVID-19 continues apace

A week and a half ago, a “study” published on “HCQ Trial” by an anonymous source claiming to be a group of PhD scientists went viral. It claimed that countries that used hydroxychloroquine to treat COVID-19 had a 79% lower fatality rate than those who didn’t. It was horrible science and quickly debunked on Twitter by several epidemiologists. That didn’t stop it from going viral. Disinformation like this during a pandemic is one of the most dangerous challenges we face.

A mere two weeks ago, I characterized the antimalaria drug hydroxychloroquine (HCQ) as the Black Knight of COVID-19 treatments. The reason is that evidence randomized controlled clinical trials (RCTs) can’t seem to kill the claims of advocates that the antimalarial drug hydroxychloroquine is a highly effective treatment for COVID-19. One example I discussed was the Newsweek article by a Yale epidemiologist named Harvey Risch that was rife with bad arguments, cherry-picked studies, and a reliance on less rigorous retrospective observational studies over the RCTs that have been published over the last couple of months. Unfortunately for Prof. Risch, the RCTs published thus far have consistently failed to find a benefit to using the drug to treat COVID-19, be it in hospitalized patients, in patients with disease mild enough to be treated as outpatients (with or without the magic drug azithromycin, which Didier Raoult insists to be an essential component of treatment), or as post-exposure prophylaxis to prevent the development of symptomatic COVID-19 in patients who had had close contact with patients with known COVID-19. Elsewhere, I noted a truly ridiculously incompetent “study” touted by the John Birch Society-like group masquerading as a medical professional society, the Association of American Physicians and Surgeons (AAPS), that claimed to find that countries that adopted the use of hydroxychloroquine to treat COVID-19 had fewer fatalities than those that did not use the drug.

Given the drip-drip-drip of negative studies of hydroxychloroquine to treat COVID-19 and my having written about the issue so recently, I didn’t think I’d have to revisit it again so soon. After all, it seemed like a long time since the likes of Donald Trump, Peter Navarro, and Vladimir Zelenko had been promoting the drug. Boy, was I mistaken! Never did I suspect that somewhere, somehow, someone would double down on the disinformation first spread by AAPS, in order to continue to tout hydroxychloroquine to treat COVID-19. This comparison of various countries, as you might recall from my recent post, first made an appearance in a court filing by the AAPS in its lawsuit against the FDA to get it to reinstate its ill-advised emergency use authorization (EUA) for hydroxychloroquine to treat COVID-19, which was revoked in June as evidence accumulated that it did not work and might actually be dangerous, due to the cardiac arrhythmias that the drug can cause. You might also recall that Harvey Risch himself alluded to a claim that countries that used hydroxychloroquine had fewer fatalities from coronavirus than those that had banned its use to treat COVID-19, a claim so ludicrous that Risch really deserves to have his title of epidemiologist stripped from him unceremoniously. Certainly, many faculty at Yale are embarrassed by his poorly constructed arguments.

But let’s get to the “study,” shall we?

A shadowy cabal of “scientists” @CovidAnalysis try to do science on a website

If there’s one thing that I’ve learned, it’s that denialists never admit when their argument is refuted or so ridiculous as to deserve mockery. Instead, they double down, as a shadowy cabal claiming to represent legitimate scientists did late last week:

The “study” on the website spread far and wide among the usual sources, such as FOX News:

Notice what the “study” is being called: “Early treatment with hydroxychloroquine: A country-randomized trial”. Here’s a hint: There’s no such thing as a “country-randomized trial”. It’s a meaningless term. Subjects were not “randomized by country.” They couldn’t have been. This is a retrospective study. (More on that later.) As biology professor Carl Bergstrom notes:

I agree. I’d never heard the term “country-randomized trial” before this website. None of this stops the website authors from publishing this “abstract“:

Many countries either adopted or declined early treatment with HCQ, forming a large country-randomized controlled trial with 2.0 billion people in the treatment group and 663 million in the control group. As of August 8, 2020, an average of 39.6/million in the treatment group have died, and 443.7/million in the control group, relative risk 0.089. After adjustments, treatment and control deaths become 82.0/million and 637.0/million, relative risk 0.13. Confounding factors affect this estimate, including varying degrees of spread between countries. Accounting for predicted changes in spread, we estimate a relative risk of 0.21. The treatment group has a 79.1% lower death rate. We examined diabetes, obesity, hypertension, life expectancy, population density, urbanization, testing level, and intervention level, which do not account for the effect observed.

This is all utter rubbish, methods, conclusion, and all, as you will see. It’s so bad that it reminds me of a study by two antivaxxers without any qualifications in epidemiology, Neil Z. Miller and Gary S. Goldman, that tried to correlate the number of vaccines in the recommended vaccine schedules of various countries with those countries’ infant mortality rates. So bad was the study that Miller and Goldman actually tried to use linear regression to correlate the number of vaccines with infant mortality rates, while cherry picking the countries chosen to be included in the analysis. @CovidAnalysis at least spared us the shenanigans misusing linear regression analysis, but he/she/it/they sure did do the same sort of cherry picking, as you will see.

Before coming back to this part, let’s go to the HCQ Trial website to look at a bit more, namely the claimed “methods”. There’s so much wrong in this website that it’s hard to know where to start, but I guess the best place is in the “conclusions” made by this “study”. No, on second thought, the best place to start is to mention that this is not a peer-reviewed study. It’s a website, nothing more. (It’s also a Twitter account, @CovidAnalysis.) It’s also a website whose creators are not just unknown but who went to a fair amount of trouble to hide who they are. The domain’s WHOIS entry is masked by Contact Privacy Inc. No one (that I know of) has yet been able to figure out who’s behind this website, but the FAQ claims:

Who is @CovidAnalysis? We are PhD researchers, scientists, people who hope to make a contribution, even if it is only very minor. You can find our research in journals like Science and Nature. For examples of why we can’t be more specific search for “raoult death threats” or “simone gold fired”. We have little interest in adding to our publication lists, being in the news, or being on TV (we have done all of these things before but feel there are more important things in life now).

They’re published in Science and Nature? Sure they are. Sure they are. Alternatively, maybe one of them has gotten published in one of those journals, just not on a topic having anything to do with COVID-19, coronaviruses, SARS-CoV-2, epidemiology, clinical trials, or any other scientific discipline relevant to determining if hydroxychloroquine is efficacious against COVID-19. My guess is that there are probably some scientists in this group who, like the scientists who attack climate science or evolution, are not actually climate scientists or evolutionary biologists and demonstrate it with their obviously shallow understanding of the relevant disciplines. I will also say, right here, right now, quite clearly that the proper way to do this sort of thing, if you’re a real scientist, is to publish it in the peer-reviewed biomedical scientific literature, not to publish an anonymous website, with no names and no affiliations. That reeks of astroturfing. In fact, this whole website reeks of astroturfing. (Astroturfing, for those not familiar with the term, means the promotion of a message as though it’s coming from the grassroots when in reality it’s coming from a company, political party, political group, or ideological group.)

Let’s dive in, though. It’s important to call out astroturfing, and it’s also important to post, for the record, an explanation of why this astroturf “study” is such bad science and does not show what its creators (whoever they are) want you to think it shows.

The “HCQ Trial”

The first thing that I noticed about this “study” is that it very aggressively co-opts the use of the language of RCTs. This is clearly to give the impression that what this group, whoever is in it, is doing is akin to an actual RCT. It’s not. Here is the current language:

Treatment. We investigate early or prophylactic treatment for COVID-19 with hydroxychloroquine (HCQ), which has been adopted or declined in different countries. Since the severity of COVID-19 varies widely based on age and comorbidities, treatment was generally only initiated in higher risk individuals. The primary endpoint was death.

Treatment groups. Entire countries made different decisions regarding treatment with HCQ, essentially assigning themself to the treatment or control group. For the purposes of this study, selection into the treatment or control group was based on the same information and is essentially random.

However, biology professor Carl Bergstrom caught @CovidAnalysis doing this:


I’m with Prof. Bergstrom. This backtracking implies that the authors of the website realized after seeing all the criticism online and on Twitter that they had gone a bit too far co-opting the language of RCTs to their deceptive purpose. Again, this reeks of astroturfing.

Let’s go through the “trial” itself, though. Certainly, whoever wrote this website is good at sounding “science-y” and as though they know what they’re talking about with respect to clinical trials. They did, for instance, cite a primary endpoint, death, and all good clinical trials have to have a primary endpoint that is measured.

Let’s consider, though, what constitutes a “randomized controlled clinical trial”. First off, RCTs are interventional studies, meaning that they study an intervention, be it a drug, a surgical procedure, implantation of a device, or whatever treatment. Most importantly, RCTs study interventions whose use can be controlled by the people doing the study. Say, for instance, that I want to determine if Drug X works to treat Condition Z. The classical RCT design would be to randomly assign subjects with Condition Z to receive either Drug X or a placebo, and ideally the study would be double blind, meaning that neither the subjects nor the investigators would know which subjects were getting Drug X or placebo. (The reason for this is because, for subjective symptoms, there are “placebo effects”, in which some subjects receiving placebo will report improvement even though they are receiving an inactive compound.) Even better would be “triple blind,” in which the statisticians analyzing the data from the trial don’t know which group received the experimental drug and which received the placebo until after they had done the analysis, after which everyone is “unblinded.”

Another important point here is that the randomization occurs at the level of the individual, and it also tries to balance out the control group and the group receiving Drug X in such a way that they are comparable in age, sex distribution, disease severity, and comorbidities, so that there isn’t a result that’s not due to the use of the drug; e.g., if one group is significantly older than the other or has significantly more serious disease than the other. Indeed, much effort goes into making sure that treatment assignment results in groups that are well-balanced in age, disease severity, and other potential confounding factors that might affect the primary outcome being studied. Finally, RCTs are prospective. That means that the subjects are assigned to treatment group before treatments are administered, not after, and then outcome observations are made. Moreover, the variable (treatment) being studied is independent, and the outcomes are the dependent variable.

None of these characteristics apply to the HCQ Trial. Countries were not “randomized” to receive hydroxychloroquine or not. Countries made decisions about whether to use hydroxychloroquine based on their leadership, their situation, belief of the medical profession in each country regarding whether hydroxychloroquine might work, and many other factors, known and unknown. This doesn’t even account for differences in the use of hydroxychloroquine in different areas of the same country. I’ll refer to Harvey Risch’s claim that I mentioned in my recent post, where Risch referred to a “natural experiment” in Brazil in which the northern Brazil state of Pará purchased 75,000 doses of azithromycin and 90,000 doses of hydroxychloroquine in April, supposedly resulting in a 7/8 decline in mortality within a month. The bottom line is that there is no way one can “randomize” countries to use a drug or not. It’s gibberish. It’s nonsense. The claim is an insult to the intelligence of epidemiologists and clinical trialists, who will immediately recognize it for the BS that it is. Unfortunately, if you don’t know anything about epidemiology or clinical trials, you might think this characterization sounds reasonable, leading to the conclusion that the use of hydroxychloroquine resulted in 79% fewer deaths per capita than in nonuse of hydroxychloroquine did, on a country-by-country basis.

If we were to give @CovidAnalysis the benefit of the doubt (which I’m not inclined to do but will do for a moment for the sake of discussion), taking this “study” at face value, I would characterize it as a retrospective ecological study, as was pointed out on Twitter:

You can also tell this, in part, by this passage:

We focus here on countries that chose and maintained a clear assignment to one of the groups for a majority of the duration of their outbreak, either adopting widespread use, or highly limiting use. Some countries have very mixed usage, and some countries have joined or left the treatment group during their outbreak. We searched government web sites, Twitter, and Google, with the assistance of several experts in HCQ usage, to confirm assignment to the treatment or control group, locating a total of 193 relevant references, shown in Appendix 12. We excluded countries with <1M population, and countries with <0.5% of people over the age of 80. COVID-19 disproportionately affects older people and the age based adjustments are less reliable when there are very few people in the high-risk age groups. We also excluded countries that adopted early widespread use of masks because these countries tend to have significantly lower spread, which we discuss in detail below.

Notice how the authors are doing all sorts of adjustments for confounders after assignment? That’s something that’s necessary in retrospective studies. I will admit to being somewhat amused by the mention of excluding countries that adopted early widespread use of masks. In general hydroxychloroquine believers tend also to be antimaskers (i.e., people who falsely claim that the widespread use of masks doesn’t slow the spread of COVID-19 and might even be harmful.) It’s funny how, when the rubber hits the road and hydroxychloroquine believers want to try to sound convincing, they actually concede that the widespread use of masks can dramatically slow the rate of COVID-19 spread. I also can’t help but cite Edward Nirenberg here:

Yes, it’s utterly ridiculous to claim 2.7 billion subjects as the sample size for this study. Even if such a study could be done, it would be utterly unethical, absent informed consent, and, like Ed, I’d love to see those 2.7 billion signed informed consent pages.

I also note, as Ed does too, that per capita mortality is not the appropriate primary endpoint, given that per capita mortality will be highly dependent on the prevalence of COVID-19:

But let’s get back to what this trial really is, a retrospective observational ecological trial, and that’s even assuming that the authors did things correctly, something I do not assume. What is an ecological trial? Basically, it’s an epidemiological study in which the unit of analysis is not the individual person, but rather the group. I’ve discussed this issue before (here and here, among other times), in particular the “ecological fallacy,” which states that ecological studies are particularly prone to false positives. One of the best explanations of the ecological fallacies I’ve seen is from an epidemiologist by the ‘nym of EpiWonk. Unfortunately, the article is no longer there. Fortunately, there is the almighty Wayback Machine at, where EpiWonk defines the ecological fallacy as “thinking that relationships observed for groups necessarily hold for individuals””:

The ecological fallacy was first described by the psychologist Edward Thorndike in 1938 in a paper entitled, “On the fallacy of imputing the correlations found for groups to the individuals or smaller groups composing them.” (Kind of says it all, doesn’t it.) The concept was introduced into sociology in 1950 by W.S. Robinson in 1950 in a paper entitled, “Ecological correlations and the behavior of individuals,” and the term Ecological Fallacy was coined by the sociologist H.C. Selvin in 1958. The concept of the ecological fallacy was formally introduced into epidemiology by Mervyn Susser in his 1973 text, Causal Thinking in the Health Sciences, although group-level analyses had been published in public health and epidemiology for decades.

To show you one example of the ecological fallacy, let’s take a brief look at H.C. Selvin’s 1958 paper. Selvin re-analyzed the 1897 study of Emile Durkheim (the “father of sociology”), Suicide, which investigated the association between religion and suicide. Although it’s difficult to find Selvin’s 1958 paper, the analyses are duplicated in a review by Professor Hal Morgenstern of the University of Michigan. Durkheim had data on four groups of Prussian provinces between 1883 and 1890. When the suicide rate is regressed on the percent of each group that was Protestant, an ecologic regression reveals a relative risk of 7.57, “i.e. it appears that Protestants were 7½ times as likely to commit suicide as were other residents (most of whom were Catholic)….ln fact, Durkheim actually compared suicide rates for Protestants and Catholics living in Prussia. From his data, we find that the rate was about twice as great among Protestants as among other religious groups, suggesting a substantial difference between the results obtained at the ecologic level (RR = 7.57) and those obtained at the individual level (RR = 2).” Thus, in Durkheim’s data, the effect estimate (the relative risk) is magnified by 4 by ecologic bias. In a recent methodological investigation of bias magnification in ecologic studies, Dr. Tom Webster of Boston University shows that effect measures can be biased upwards by as much as 25 times or more in ecologic analyses in which confounding is not controlled.

Another epidemiologist, Gideon M-K (a.k.a. the Health Nerd) explains this fallacy thusly:

The basic idea of the fallacy is this: you cannot directly infer the properties of individuals from the average of a group. Sounds complicated, but what that means is that if you measure something about lots of people — say, height — you can’t take the average measurement as an indication of any particular person’s status.

There’s a really simple example of this to do with means, or averages. Imagine you’ve got two groups of ten people, A and B. Group A has an average height of 170cm, and group B has an average height of 168cm. If you randomly select one person from each group, who is more likely to be taller, someone from group A or B?

The intuitive reaction is to say that someone from A is going to be taller than B, because the mean height is higher. However, this is not necessarily true. You can have a mean height of 170cm caused by two 200cm giants and eight 162.5cm people, and a mean of 168cm with six 170cm people and four 165cm people. In this case, 80% of group A is shorter than everyone in group B, which means that you’ll almost always get a taller person in group B if you pick randomly.

In other words, the average of a group isn’t always representative of the individuals.


That’s right. The sample size is actually rather small. It’s not billions. It’s 36.

@CovidAnalysis does try to control for some confounders, but even then they do it badly. For instance, in trying to control for obesity, a known risk factor for death from COVID-19, the authors cite the CIA World Factbook:

Let’s just put it this way. You can’t use out-of-date information to apply to a population and control for a potential confounder.

@CovidAnalysis also notably leaves out several countries (such as France, where hydroxychloroquine use was quite high, spurred on by Didier Raoult, whose atrociously awful science about hydroxychloroquine and azithromycin as treatments for COVID-19 have been a frequent topic of this blog and doesn’t explain why, as @BadCOVID19Takes points out:

In addition, as several critics have noted, using the number of deaths normalized to the entire population (deaths per capita), rather than the case fatality rate (deaths per cases of symptomatic COVID-19 infection) or infection fatality rate (deaths per cases of all COVID-19 infections, symptomatic or asymptomatic), is meaningless because the number of deaths per capita will depend a lot on how many infections there are in the population. Worse, the authors didn’t control for other measures undertaken by the various governments to control the spread of COVID-19 other than mask wearing, and—guess what!—they didn’t even control for that very well:

And they didn’t control for lockdowns at all:

Oops! Also: Incompetence or dishonesty? You be the judge!

Before you answer, look at Appendix 12. Look at the sources. They include primarily Tweets from anonymous pro-hydroxychloroquine accounts like Covid19Crusher and ChloroquineGuerilla, and news stories.

There are so many things wrong with this “study” that it’s hard to keep track of them all:

  • It’s not a randomized controlled trial by any stretch of the imagination
  • It’s an observational ecological study (sort of) prone to the ecological fallacy
  • Confounders are not properly controlled for, particularly mask wearing and lockdowns
  • It’s not peer-reviewed
  • Its sample size is 36, not 2.7 billion
  • It is not known why only 36 countries were selected, and why these 36, which reeks of cherry picking
  • It misreports the results of at least one study, if not several
  • It doesn’t actually determine how much hydroxychloroquine was actually used in the “HCQ countries” or whether and how much it was used in some of the “non-HCQ countries”
  • It does not define what it means by “early” versus “late” treatment

I could go on and on and on, but I’m already tired. Suffice to say that this is an utterly worthless “study” whose “results” are utterly meaningless.

Who is @CovidAnalysis

As I’ve said before, the website reeks of astroturfing. It’s amusing to look at the Acknowledgments section, though:

It doesn’t, however, get us closer to who this is. Also, as noted here, this is just one website that appears to be part of a shady web of websites by one person or entity:

I do have my suspicions, though. Remember how two weeks ago (and earlier in this post) I pointed out that AAPS was the first to use this sort of analysis in its court filings for its lawsuit against the FDA trying to get the FDA to reinstate its EUA for hydroxychloroquine for COVID-19? Yes, I’m very suspicious that AAPS is behind @CovidAnalysis and the website and its incredibly deceptive “analysis”. On the AAPS website, there is an article from August 6 promoting hydroxychloroquine for COVID-19 that concludes:

For information on the “natural experiment” of early use vs. nonuse of HCQ—a 79% difference in mortality—see

That’s admittedly weak evidence, although suggestive. Also, in one of the AAPS filings (dated July 20, 2020), it states:

None of Defendants’ arguments justifies their senseless interference with access by the public to hydroxychloroquine, a medication having a 65-year track of safety with numerous studies demonstrating its effectiveness as an early treatment against COVID-19 as compiled independently on the website.

The website is one of the websites that appears to be affiliated with Indeed, a software engineer noted:

None of this, of course, is any sort of slam-dunk evidence that AAPS is behind this. It’s highly circumstantial. It’s also possible that whoever is behind this web of pro-hydroxychloroquine sites is has nothing to do with AAPS, but that the and websites are simply useful repositories of disinformation for AAPS to use. Either way, it’s clear that these sites are all related and that they are all spreading the same sort of disinformation.

Unfortunately, there is a network of websites and news media willing to amplify this disinformation, and social media further facilitates its spread. The website is obvious pseudoscience to anyone who has any expertise in epidemiology and/or clinical trials, but unfortunately it has spread far and wide faster than experts could debunk its disinformation. Such is the age we are living in. Sadly, it’s been a week and a half since this bit of disinformation hit social media, and it shows little sign of slowing.

By Orac

Orac is the nom de blog of a humble surgeon/scientist who has an ego just big enough to delude himself that someone, somewhere might actually give a rodent's posterior about his copious verbal meanderings, but just barely small enough to admit to himself that few probably will. That surgeon is otherwise known as David Gorski.

That this particular surgeon has chosen his nom de blog based on a rather cranky and arrogant computer shaped like a clear box of blinking lights that he originally encountered when he became a fan of a 35 year old British SF television show whose special effects were renowned for their BBC/Doctor Who-style low budget look, but whose stories nonetheless resulted in some of the best, most innovative science fiction ever televised, should tell you nearly all that you need to know about Orac. (That, and the length of the preceding sentence.)

DISCLAIMER:: The various written meanderings here are the opinions of Orac and Orac alone, written on his own time. They should never be construed as representing the opinions of any other person or entity, especially Orac's cancer center, department of surgery, medical school, or university. Also note that Orac is nonpartisan; he is more than willing to criticize the statements of anyone, regardless of of political leanings, if that anyone advocates pseudoscience or quackery. Finally, medical commentary is not to be construed in any way as medical advice.

To contact Orac: [email protected]

54 replies on “The astroturf effort promoting hydroxychloroquine as a treatment for COVID-19 continues apace”

hhmmm too many cooks in the kitchen…me thinking …happy bob from oz …8

Who is @CovidAnalysis? We are PhD researchers, scientists, people who hope to make a contribution, even if it is only very minor. You can find our research in journals like Science and Nature. For examples of why we can’t be more specific search for “raoult death threats” or “simone gold fired”. We have little interest in adding to our publication lists, being in the news, or being on TV (we have done all of these things before but feel there are more important things in life now).

Let me summarize: “Identities and credentials? We ain’t got no identities and credentials. We don’t need no identities and credentials. We don’t have to show you any stinkin’ identities and credentials!”

And: “trust us. We said we are scientists on the internet.
Don’t trust all those other scientists.”

So true!
What gets me is that many of those I survey instruct their followers to not trust experts, consensus science, governmental bodies, universities or the media BUT
to trust them.
Although I know that they go through contortions creating facsimile resumes to convince their audiences about their superior knowledge and morality but it’s ONLY THEM saying it!

Ohh, it’s the real good stuff (don’t forget the zinc; zinc is good, stuff or no stuff).

It’s embraced by Housing and Urban Development Secretary Ben Carson and MyPillow founder and CEO Mike Lindell, a big Trump backer, who recently took a financial stake in the company that develops the product.

Lindell told Axios that in the meeting, Trump “basically said: …’The FDA should be approving it.'”
MyPillow CEO Lindell, who is a major advertiser on Fox News and a personal friend of Carson and Trump, helped Whitney get an Oval Office meeting with the president in July to discuss oleandrin as a potential COVID-19 cure.
… Lindell spoke passionately in support of oleandrin and said he was such a believer in the botanical that he now has a financial stake in Phoenix Biotechnology and wants to ensure every American has access to this COVID-19 “cure.”
Lindell said he first became aware of oleandrin when Whitney called him on Easter Sunday and said it could cure COVID-19.
Told about the alarm inside the administration regarding his promotion of oleandrin, Lindell said, “This is the most amazing miracle thing I’ve ever seen in my life, so I went all in…. If you want to know what I think, I think it’s being suppressed because somebody doesn’t want this out there because it works.”

I know, I know, ‘toxic cardiac glycocide’ yada yada yada.

“I’m here to give you the best sleep of your life!” — MyPillow guy

I dropped in to snark on the My Pillow guy if no one else had, though I guessed Tim might have been on it already, and sure enough he has. As a native Minnesotan, Lindell galls me no end. Just when we finally ushered Michelle Bachmann off the stage, we get this toxic clown.

Speaking of toxic clowns, although not as outre as pimping oleadrin, far closer to the seat of power we have new COVID task fore member Scott Atlas – who, despite the name is neither a pron actor nor pro wrestler but an MD and “Health Policy Expert” backed by the Hoover (!) Institute at Stanford but known mainly for his Hot Takes on Fox News. Surprise, surprise, his talking points are:
“it doesn’t matter ‘how many cases’ there are in the US…
“those under 18 years old have ‘essentially no risk of dying’ …
“teachers who are at high risk for contracting Covid-19 should ‘know how to protect themselves’…
“children almost never transmit the disease'”
blaming “a rise in cases in southern states on protests and border crossings”,
“decrying the idea that schools cannot reopen this fall as ‘hysteria’ and pushing for the resumption of college sports.

While he’s a real MD [I bet you guessed this part] he’s a radiologist with no specific training or career expertise in epidemiology and/or infectious disease. [Needless to say (Hoover) he wants to repeal the ACA and privatize Medicare and Medicaid.]

Thankfully, he’s not from Minnesota.


Yet another Fox-derived yes-man to stuff up the works (drain the swamp? top off a cesspool?). If government and civics were a car alternator, it is, as if, it has been rewired into a compulsator with Limbaugh as stator feedback control circuitry gone horribly wrong — only good for powering a feces-flinging rail gun in inconsistent orange splurts.

What have you got to lose? Just take it. Take it. {Scott Atlas, I mean}

It’s hard to be surprised by this in an age of a billions-of-dollars-a-year supplement industry and coverage of acupuncture and chiropractic by Medicare and Medicaid. The horse has been our of the barn since the DSHEA in 1994.

There are over 3000 trials on Covid-19 listed on including 650 in the U.S. and 99 in Canada. None of them include oleandrin. In fact, there are no trials at all listed for oleandrin.

More smoke and mirrors.

Phoenix Biotechnology doesn’t have a single trial registered at, much less one for oleandrin. So they need to start doing their basic research.

A recent article in Nature reported 21 other candidates, 4 of which have been shown to be synergistic with remdesivir.
So why not pursue one of these drugs instead?

I think it was a different release on this same study that listed five FDA-approved drugs that could work against COVID, the team reported, include ViiV’s Ziagen and Bristol Myers Squibb’s Zerit, both used to treat HIV; Roche’s Valcyte and Gilead’s Vistide for cytomegalovirus; and BMS’ Baraclude for hepatitis B.
Or perhaps EIDD-2801?
“These seven deadly plants, flowers and shrubs could kill you if eaten

In no particular order, here are seven of the deadliest plants in the world:
2. Oleander (Nerium oleander)
Though commonly grown as a hedge and ornamental, all parts of the oleander plant are deadly and contain lethal cardiac glycosides known as oleandrin and nerine.

If eaten, oleander can cause vomiting, diarrhoea, erratic pulse, seizures, coma, and even death. Contact with the leaves and sap alone is known to irritate skin. In fact, the toxins in oleander are so strong that people have become ill after eating honey made by bees that visited these flowers!”
“I’ll have a double shot of that untested, unproven snake-oil cure for my COVID-19”, said no sane person ever.
I say make it over-the-counter for all the woo-woos to take… /sarc
First mention of oleandrin and COVID AI could find was at the fake news site:
Notice how Phoenix Biotechnology is one of the founding promoters of this rank idiocy and has now got DJT’s ear…
AARP discussion thread on this from April where an oleandrin shill gets smacked down for promoting fake news and quacks:
Same as it ever was…
Same as it ever was.

Orac has written about Oleander for cancer ( see Search box).
I guess in desperation, woo-meisters look for cures used for cancer or hiv/aids – that also didn’t work.
There is nothing new under the sun or in alt med’s armamentarium

Season 7 episode 2, Mr. Monk and the Genius (David Strathairn) demonstrated Oleander being used nefariously (he kilt his wives with it).


It is amazing what commenters on a certain right wing site are bouncing around: from the media derides only because it’s ‘Christian’ Mike Lindell to irresponsible to report on it before Trump makes a decision because ‘fish tank cleaner incidents’.

What could be up next? Heracleum mantegazzianum??

@squirrelelite –
Dr. Jen Gunter has been on this:
Her twitter acc’t:
Her tweet addressing this:
The cited David Juurlink’s account:
His tweet addressing the lethal concentrations of oleandrin:
Click left image to see this quote:
“In comparison with data from literature it seems clear that such concentrations reflect an acute poisoning. In fact, blood levels of about 1-2 ng/ml of leandrin are regarded as toxic 9,10 and cases of fatal acute poisoning are described for blood levels of about 9.8-10 ng/ml.6,11”
sciencedirect citation from Juurlink’s tweet:
The article is paywalled and I don’t have access so I’m going to have to take Juurlink’s word for the statement but I would think Gunter would have checked to make sure everything was kosher.
So it appears that the manufacturer of this dangerous, deadly, and untested oleandrin product has got Trump’s ear and is pushing hard for it…
There’s no conflict of interest there, is there?
It also appears that Phoenix Biotech. is the genesis for this quackery with help from a guy who makes very expensive pillows.

“Oleander can cause vomiting, diarrhea, erratic pulse, seizures, coma, and even death.” So what? [/s] Are those not already all the symptoms of Trumpism?


Ahh, how could I forget that NCIS. Oh. I know, it was because it is all a blur of Polly Parrot and Caf-Pow slurpies.

But also add:
” Ingrid murders him with a poison made from white oleander. Ingrid is arrested and sentenced to life in prison, leaving Astrid under the care of the state of California.”

What could possibly go wrong? When questioned at the yellicoptor conference this morning, Trump replied “idk,is that something alot* of people are talking about?” {or words to that effect}

*is it good for ratings?

This is not going to be a thing. It’s just not; especially when ‘the base’ learns of it’s prominent use for suicide and as an abortifacient by the shithole country Heathens of the East.

That will never fly over the counter here; I can’t even get hydroxyzine. Look what these people did over weed, mushrooms — botanicals that do work — these last many decades and the millions and millions incarcerated*. I feel trolled.

*fuck you, Kumala; You turned loopholes into weapons to cement injustice.

Use big words and speak with confidence and you can convince people you’re an expert, or at least knowledgeable. It’s a common con. Fortunately there are folks like Orac, Dr. Bergstrom and others to expose the con. Unfortunately, too many people don’t bother to double check claims or are willing to accept what’s told to them that confirms their biases.

Well…I just returned to the inpatient service and am happy to report that the COVID committee finally dumped HCQ and AZT three weeks ago. Guess what? Outcomes are unchanged across the hospital system (About eleven affiliated hospitals in six states including the PNW and the South.) They were doing zinc, too. Some attendings are still using it for reasons unknown but it dropped as an official recommendation. On the outpatient side we have done nothing but recommend convalescence, supportive measures, and isolation since the beginning and our numbers, if anything, are better than the general numbers for patient outcomes in the counties our clinics are located in-this with a population of low means loaded with comorbidities. Just one experience from the “Frontline” but there it is.

Since the main evidence for HCQ is in vitro studies in vero cells, I think I’ll copy this info that I posted on the astroturf thread on SBM.

Speaking of petri dishes, there were two important papers published in Nature recently.

Here, we show that engineered expression of TMPRSS2, a cellular protease that activates SARS-CoV-2 for entry into lung cells4, renders SARS-CoV-2 infection of Vero cells insensitive to chloroquine. Moreover, we report that chloroquine does not block SARS-CoV-2 infection of the TMPRSS2-positive lung cell line Calu-3. These results indicate that chloroquine targets a pathway for viral activation that is not operative in lung cells and is unlikely to protect against SARS-CoV-2 spread in and between patients.

We evaluated the antiviral activity of HCQ both in vitro and in SARS-CoV-2-infected macaques. HCQ showed antiviral activity in African green monkey kidney cells (VeroE6) but not in a model of reconstituted human airway epithelium. In macaques, we tested different treatment strategies in comparison to placebo, before and after peak viral load, alone or in combination with azithromycin (AZTH). Neither HCQ nor HCQ+AZTH showed a significant effect on the viral load levels in any of the tested compartments. When the drug was used as a pre-exposure prophylaxis (PrEP), HCQ did not confer protection against acquisition of infection. Our findings do not support the use of HCQ, either alone or in combination with AZTH, as an antiviral treatment for COVID-19 in humans.

So all these proposed treatments should be using Calu-3 cells instead of the Vero cells.

Fauchi totally whacked that wanted-to-take-a-walk Trial before his time was up! Monster!

While “country-randomized” doesn’t seem to exist, there most certainly is something called a “community-randomized” trial. This is primarily used for testing systems of care, which are applied at the community level, rather than at the level of specific individuals. Smoking cessation campaigns are an example. Systems for IRB oversight and consent by community representatives are used. See Green Controlled Clinical Trials, v18(6):506-513

Clive is the Australian Donald Trump. A shady businessman who thinks he should be running the country.

Not only did he buy up a lot of HCQ when Trump first promoted it, he took out full page advertisements in the newspapers for weeks promoting the fact that he had done so. He is in bother with the courts over dodgy dealings with Queensland Nickel, perhaps he wanted to use this as a distraction or to make enough to pay off the creditors.

Simp, no he is clever enough at ripping off investors. Crook, rorter or bullsh!t artist would be more common, depending on the age of the speaker and the aspest they wish to describe.

Oleander is not much of a threat. Like a lot of poisonous plants, it tastes so bad that nearly no creature will eat it. Once upon a time there were a bunch of healthy oleander bushes in my yard, planted by my father, pleasant to look upon, not especially showy, but my late sister-in-law freaked out about them. Oh, well.

When a teenager I bought a paperback entitled “Handbook for Poisoners”, which was actually a collection of short stories involving poison, one including oleander, with a lengthy and reasonably informative introduction. What I found most amusing was the observation that, at the height of the practice of poisoning as statecraft in the Middle Ages, the concoctions were often so rebarbative that the intended victims spewed them out before they could take effect.

I’ve later seen it suggested that ground glass may also not be especially lethal. Consider sand.

Several years ago the Tucson Zoo lost 2 giraffes because a newer employee fed them some oleander branches from the oleanders the encircled the zoo. So, some animals will eat this. FYI there are no more oleanders anywhere near the Tucson Zoo after that tragedy.

Deja vu on oleandrin: its predecessor was Anvirzel, a cocktail of oleandrin and another component isolated from oleander. It was supposed to be good for treating cancer, hepatitis C, AIDS, congestive heart failure and probably other things as well. From what I can tell, it never passed phase 3 trials for cancer if it reached them at all (one phase 1 trial found that Anvirzel had “no objective effect” on solid tumors).

There are probably diehards still promoting home-brewed versions concocted from the raw plant, affectionately known as “oleander soup”. One such loon with a CureZone franchise came over to RI to harangue us back in the day, outraged that Orac didn’t share his enthusiasm.

Oleander, aside from being ineffective against cancer, has nasty side effects similar to those of the chemotherapeutic agents it was supposed to replace. Advocates claimed that when “oleander soup” caused recipients to vomit and become diarrheic, that was just the body expelling toxins, not a toxic effect of oleander itself – an excuse familiar to alt med skeptics.

Thanks to Trump, it’s 1995 all over again.

*I’m growing a reputedly fragrant oleander in the garden this year. Even if it doesn’t flower it should be good for what ails me.

” One such loon with a CureZone franchise came over to RI to harangue us back in the day, outraged that Orac didn’t share his enthusiasm.”

I wonder if you would care to comment on the more advanced oleander medicine now in initial FDA testing at MD Anderson in Houston (and having great reports, btw)?

Or perhaps you would have some words of wisdom for the most recent two pancreatic patients who use the patented medicine available from Honduras by FDA exception rule who, after 6 months have either no cancer in one instance and completely halted tumor growth in the other?

Should I pass on your sage wisdom to my Yahoo Health Group of over 1000 members which I have hosted for over five years, including members with pancreatic and a great number of members who mainstream oncologists told to go home and say goodbye to family and friends, settle their affairs and pick out a burial spot

Well, well, well. Could this be “the thousand people” Lindell keeps referring to?

in fairness, I strongly think he said “scale” instead of “sell” @19:55

So who has an interest in doing this much work to set up an HCQ scam site? This is not a trivial amount of time and effort, and it required multiple people, some of whom were enough versed in medical science to construct a sound-alike nemisis. What’s the benefit to the entity who constructed all this?
Despite the obfuscating, there should be some way to find out who posted this. Such information leaks.
A foreign country, perhaps?

I was part of a trial through the Duke Hospital system for that stuff when I was hospitalized back in June (had pneumonia in both lungs thanks to our new best friend), and some of the specific side effects they were looking for in the follow ups were pretty concerning. Good to see the harpies are still shrieking loud enough to waste time and money on research into this stuff.

Tim found the oleander enthusiast to whom I was referring, Tony Isaacs, who raked Patrick Swayze over the coals for rejecting alt med treatment of his advanced-stage pancreatic cancer.

I was mildly curious if Isaacs was gloating about Trump’s new flirtation with oleandrin, so I did a brief Google search. Sadly, Isaacs died earlier this year after hospitalization for cardiac bypass surgery and a number of complications, which may have been related to his diabetes. After confidently assuring us that “only Nature heals”, Mr. Isaacs turned to mainstream medicine for help, while bitching profusely on his Facebook page about how his misguided caregivers were overlooking Nature’s cures, for instance cardioverting his atrial fibrillation instead of relying on hawthorn syrup.

However I didn’t see any mention of oleandrin.

“Sadly, Isaacs died earlier this year after hospitalization for cardiac bypass surgery”


Cardiac problems, huu? The stuff the ol’ander is good for?
No. No, I’m not thinking Lindell and crew bumped him off for personal gain. {Of course I am} /!s

Maybe Lindell is selling his pillows to morticians for casket use (he could call it “My Final Pillow ™), that way he’s got his profit coming and going for oleandrin.


Man lays trap for the public.
Man falls into self-laid trap.
So sad.

Seeing how they claim to have done a trial that requires informed consent is it possible to get them person behind the twitter name unmasked if you go to twitter with that?

Comments are closed.


Subscribe now to keep reading and get access to the full archive.

Continue reading